Tirzepatide, a novel medication, is gaining traction as a potential treatment for individuals facing diabetes of type 2. Unlike common diabetes therapies, it functions through a innovative mechanism, stimulating both the GLP-1 receptor and GIP receptors. Clinical data have demonstrated that tirze